Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody

NCT03183024 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Chronic Idiopathic Urticaria

Interventions

BIOLOGICAL: benralizumab
BIOLOGICAL: placebo

Sponsor

Jonathan A. Bernstein, MD